ADAM17 and histiocytic sarcoma: In contrast to this hypothesis, Frew and Navrazhina demonstrated that no significant downregulation of Notch 1–4 was identified in HS lesional skin, whereas ADAM17 expression was upregulated in HS, in contrast with downregulation seen in other inflammatory dermatoses.